Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice

Microbes and Infection

Volumn 8, Issue 2, 2006, Pages 442-449

  Nyström, Johanna ^a   Raghavan, S ^a   Svennerholm, A M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alum; Cholera toxin; Helicobacter pylori; Mouse model; Mucosal immunity; Parenteral oral immunization; T cell response; Therapeutic immunization

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BACTERIAL ANTIGEN; CHOLERA TOXIN; CYTOKINE; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARIETAL CELL ANTIBODY; SAPONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INTERMETHOD COMPARISON; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STOMACH; STOMACH MUCOSA; STOMACH PROTECTION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHOLERA TOXIN; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; MICE; MICE, INBRED C57BL; STOMACH; T-LYMPHOCYTES;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 32244438803     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.07.010     Document Type: Article

References (24)

1. M.J. Blaser Helicobacter pylori and the pathogenesis of gastroduodenal inflammation J. Infect. Dis. 161 1990 626 633
2. B.C. Wong, S.K. Lam, K.C. Lai, W.H. Hu, C.K. Ching, J. Ho, S.T. Yuen, C.K. Chan, G.K. Lau, and C.L. Lai Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study Aliment. Pharmacol. Ther. 13 1999 303 309
3. R.E. Pounder, and D. Ng The prevalence of Helicobacter pylori infection in different countries Aliment. Pharmacol. Ther. 9 Suppl 2 1995 33 39
4. H.M. Mitchell, Y.Y. Li, P.J. Hu, Q. Liu, M. Chen, G.G. Du, Z.J. Wang, A. Lee, and S.L. Hazell Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition J. Infect. Dis. 166 1992 149 153
5. A. Mattsson, H. Lonroth, M. Quiding-Jarbrink, and A.M. Svennerholm Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination J. Clin. Invest. 102 1998 51 56
6. P. Ghiara, M. Rossi, M. Marchetti, A. Di Tommaso, C. Vindigni, F. Ciampolini, A. Covacci, J.L. Telford, M.T. De Magistris, M. Pizza, R. Rappuoli, and G. Del Giudice Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection Infect. Immun. 65 1997 4996 5002
7. S. Raghavan, A.M. Svennerholm, and J. Holmgren Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis Infect. Immun. 70 2002 4621 4627
8. B. Guy, C. Hessler, S. Fourage, J. Haensler, E. Vialon-Lafay, B. Rokbi, and M.J. Millet Systemic immunization with urease protects mice against Helicobacter pylori infection Vaccine 16 1998 850 856
9. S.J. Czinn, and J.G. Nedrud Oral immunization against Helicobacter pylori Infect. Immun. 59 1991 2359 2363
10. T.H. Ermak, P.J. Giannasca, R. Nichols, G.A. Myers, J. Nedrud, R. Weltzin, C.K. Lee, H. Kleanthous, and T.P. Monath Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses J. Exp. Med. 188 1998 2277 2288
11. A.A. Akhiani, J. Pappo, Z. Kabok, K. Schon, W. Gao, L.E. Franzen, and N. Lycke Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells J. Immunol. 169 2002 6977 6984
12. A. Lee, J. O'Rourke, M.C. De Ungria, B. Robertson, G. Daskalopoulos, and M.F. Dixon A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain Gastroenterology 112 1997 1386 1397
13. C. Lindholm, J. Osek, and A.M. Svennerholm Quantification of conserved antigens in Helicobacter pylori during different culture conditions Infect. Immun. 65 1997 5376 5380
14. S. Raghavan, M. Hjulstrom, J. Holmgren, and A.M. Svennerholm Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines Infect. Immun. 70 2002 6383 6388
15. J.M. Gottwein, T.G. Blanchard, O.S. Targoni, J.C. Eisenberg, B.M. Zagorski, R.W. Redline, J.G. Nedrud, M. Tary-Lehmann, P.V. Lehmann, and S.J. Czinn Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization J. Infect. Dis. 184 2001 308 314
16. A. Mattsson, A. Tinnert, A. Hamlet, H. Lonroth, I. Bolin, and A.M. Svennerholm Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects Clin. Diagn. Lab. Immunol. 5 1998 288 293
17. E.L. Johansson, C. Rask, M. Fredriksson, K. Eriksson, C. Czerkinsky, and J. Holmgren Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates Infect. Immun. 66 1998 514 520
18. C. Bergquist, E.L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina Infect. Immun. 65 1997 2676 2684
19. P. Sutton, J. Wilson, and A. Lee Further development of the Helicobacter pylori mouse vaccination model Vaccine 18 2000 2677 2685
20. E. Suri-Payer, P.J. Kehn, A.W. Cheever, and E.M. Shevach Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells J. Immunol. 157 1996 1799 1805
21. B. Gebert, W. Fischer, E. Weiss, R. Hoffmann, and R. Haas Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation Science 301 2003 1099 1102
22. K. Maeda, T. Yamashiro, T. Minoura, T. Fujioka, M. Nasu, and A. Nishizono Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection Microbiol. Immunol. 46 2002 613 620
23. A.A. Akhiani, K. Schon, L.E. Franzen, J. Pappo, and N. Lycke Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection J. Immunol. 172 2004 5024 5033
24. S. Raghavan, E. Suri-Payer, and J. Holmgren Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells Scand. J. Immunol. 60 2004 82 88